Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02666'
s EV-to-FCF Range Over the Past 10 Years
Min: -603.09 Med: -9.92 Max: 43.69
Current: 13.82
During the past 12 years, the highest EV-to-FCF of Genertec Universal Medical Group Co was 43.69. The lowest was -603.09. And the median was -9.92.
HKSE:02666's EV-to-FCF is ranked worse than 50.37% of 268
companies
in the Credit Services industry
Industry Median: 13.63
vs HKSE:02666: 13.82
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Genertec Universal Medical Group Co (HKSE:02666) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Genertec Universal Medical Group Co's PE Ratio (TTM) for today is calculated as:
Genertec Universal Medical Group Co's share price for today is HK$4.67.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genertec Universal Medical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.186.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Genertec Universal Medical Group Co EV-to-FCF Related Terms
Genertec Universal Medical Group Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genertec Universal Medical Group Co EV-to-FCF Chart
For the Credit Services subindustry, Genertec Universal Medical Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genertec Universal Medical Group Co EV-to-FCF vs Credit Services Industry
For the Credit Services industry and Financial Services sector, Genertec Universal Medical Group Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Genertec Universal Medical Group Co's EV-to-FCF falls into.
Genertec Universal Medical Group Co's current Enterprise Value is HK$72,732 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genertec Universal Medical Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$5,264 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genertec Universal Medical Group Co (HKSE:02666) has a EV-to-FCF of 13.82 as of Aug. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Genertec Universal Medical Group Co and its competitors. According to the industry distribution chart, Genertec Universal Medical Group Co ranks #135 out of 268 companies in the Credit Services industry, placing it in the top 50.4%.
Is Genertec Universal Medical Group Co's EV-to-FCF too high?
Genertec Universal Medical Group Co's current EV-to-FCF is 13.82. The Credit Services industry median EV-to-FCF is 13.63. Genertec Universal Medical Group Co's value of 13.82 is 1.4% above this industry median. Based on the distribution chart, Genertec Universal Medical Group Co ranks #135 out of 268 companies in the Credit Services industry, which is below the industry midpoint. Overall, Genertec Universal Medical Group Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genertec Universal Medical Group Co's EV-to-FCF compare to V and MA?
According to the Credit Services industry distribution chart, Genertec Universal Medical Group Co ranks #135 out of 268 companies for EV-to-FCF. This places Genertec Universal Medical Group Co in the lower half of its industry. The industry median EV-to-FCF is 13.63. Genertec Universal Medical Group Co's value of 13.82 is 1.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Credit Services company?
The median EV-to-FCF among Credit Services companies is 13.63, based on 268 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genertec Universal Medical Group Co's current EV-to-FCF of 13.82 is 1.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Genertec Universal Medical Group Co and its competitors. For the Credit Services industry, the median EV-to-FCF is 13.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genertec Universal Medical Group Co's current EV-to-FCF is 13.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genertec Universal Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Genertec Universal Medical Group Co (HKSE:02666) is currently considered Fairly Valued. The stock's GF Value™ is HK$4.51, compared to a current price of HK$4.67 — trading 3.5% above its estimated fair value. The current EV-to-FCF is 13.82 and 1.4% above the Credit Services industry median of 13.63. Genertec Universal Medical Group Co's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Genertec Universal Medical Group Co (HKSE:02666), the current EV-to-FCF is 13.82 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genertec Universal Medical Group Co (HKSE:02666) Overvalued in 2026?
Based on GuruFocus' analysis, Genertec Universal Medical Group Co stock appears to be overvalued.
The current stock price of HK$4.67 is trading 3.5% above its estimated GF Value™ of HK$4.51.
GuruFocus considers Genertec Universal Medical Group Co to be Fairly Valued.
Key valuation signals for HKSE:02666:
EV-to-FCF: 13.82
GF Value™: HK$4.51 vs. price of HK$4.67 (3.5% above fair value)
Industry Position: 1.4% above the Credit Services median (#135 of 268)
No single metric tells the full story. See the HKSE:02666 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The group has two business segments namely The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services; and Healthcare business comprises includes hospital group business, healthcare technology business and specialty business. Geographically, it derives a majority of its revenue from Mainland China.
84GF Score
Get the complete analysis for HKSE:02666
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02666 has been successfully added to your 
